A comparison of outcome for patients undergoing non-myeloablative stem cell transplantation compared to conventional conditioning for multiple myeloma.

被引：0

作者：

Hunter, HM

Peggs, K

Powles, R

Apperley, J

Mahendra, P

Cavenagh, J

Littlewood, T

Potter, M

Hunter, A

Pagliuca, A

Williams, C

Cook, G

Towlson, K

Marks, D

Russell, NH

机构：

[1] City Hosp Nottingham, Nottingham, England

[2] UCH, London, England

[3] Royal Marsden Hosp, London SW3 6JJ, England

[4] Hammersmith Hosp, London, England

[5] QEH, Birmingham, W Midlands, England

[6] St Bartholomews & Royal London HOsp, London, England

[7] Oxford Radcliff Hosp, Oxford, England

[8] Royal Free Hosp, London NW3 2QG, England

[9] Leicester Royal Infirm, Leicester, Leics, England

[10] Kings Coll Hosp London, London, England

[11] Christie Hosp & Holt Radium Inst, Manchester M20 9BX, Lancs, England

[12] St James, Leeds, W Yorkshire, England

[13] United Bristol Healthcare Trust, Bristol, Avon, England

来源：

BLOOD | 2003年 / 102卷 / 11期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

2705

引用

页码：732A / 732A

页数：1

共 50 条

[31] Allogeneic stem cell transplantation with non-myeloablative conditioning for Hypereosinophilic Syndrome (HES)
Juvonen, E
Volin, L
Elonen, E
Koponen, A
Ruutu, T
BONE MARROW TRANSPLANTATION, 2001, 27 : S288 - S288
[32] Non-myeloablative hematopoietic stem cell transplantation
Maris, M
Sandmaier, BM
Maloney, DG
McSweeney, PA
Woolfrey, A
Chauncey, T
Shizuru, J
Niederwieser, D
Blume, KG
Forman, S
Storb, R
TRANSFUSION CLINIQUE ET BIOLOGIQUE, 2001, 8 (03) : 231 - 234
[33] Non-myeloablative allografts following cytoreduction autotransplants for treatment of multiple myeloma.
Carella, AM
Martino, M
Beltrami, G
Console, G
Musto, P
Morabito, F
Scalzulli, PR
Iacopino, P
BLOOD, 2003, 102 (11) : 464B - 464B
[34] Non-myeloablative stem cell transplantation in adrenoleukodystrophy
Kapelushnik, J
Shapira, Y
Aker, M
Hershkoviz, E
Moser, A
Selavin, S
Or, R
BONE MARROW TRANSPLANTATION, 2003, 31 : S51 - S51
[35] Molecular monitoring of chimerism and minimal residual disease in multiple myeloma patients after non-myeloablative stem cell transplantation
Galimberti, S
Benedetti, E
Fazzi, R
Papineschi, F
Caracciolo, F
Orciuolo, E
Andreazzoli, F
Morabito, F
Cuzzola, M
Martino, M
Iacopino, P
Petrini, M
BONE MARROW TRANSPLANTATION, 2004, 33 : S112 - S112
[36] Sustained molecular remission by non-myeloablative stem cell transplantation after autologous hematopoietic stem cell transplantation in a patient with multiple myeloma
Nakashima, Y
Shiratsuchi, M
Abe, Y
Muta, K
Tani, K
Shiokawa, S
Nishimura, J
LEUKEMIA & LYMPHOMA, 2005, 46 (08) : 1217 - 1222
[37] Non-myeloablative conditioning is associated with reduced pro-inflammatory cytokine storm compared to myeloablative conditioning after allogeneic stem cell transplantation.
Tzolas, AC
Devidas, M
Mina, S
Cartwright, B
Salansky, J
Wingard, JR
Reddy, V
BLOOD, 2001, 98 (11) : 186A - 186A
[38] Immune recovery after conventional and non-myeloablative allogeneic stem cell transplantation
Schulenburg, A
Fischer, M
Kalhs, P
Mitterbauer, M
Rabitsch, W
Greinix, HT
Leitner, G
LEUKEMIA & LYMPHOMA, 2005, 46 (12) : 1755 - 1760
[39] Non-myeloablative stem cell transplantation - High stem cell dose will not compensate for T cell depletion in allogeneic non-myeloablative stem cell transplantation
Passweg, JR
Meyer-Monard, S
Gregor, M
Favre, G
Heim, D
Ebnoether, M
Tichelli, A
Gratwohl, A
BONE MARROW TRANSPLANTATION, 2002, 30 (05) : 267 - 271
[40] TRANSFUSION SUPPORT OF PEDIATRIC SICKLE CELL DISEASE PATIENTS UNDERGOING NON-MYELOABLATIVE STEM CELL TRANSPLANTATION
Collier, Israel
Wong, Edward
Tekle, Medhanite
Fasano, Ross
Paul, Wendy
Luban, Naomi
Sande, Jane
Kamani, Naynesh
JOURNAL OF INVESTIGATIVE MEDICINE, 2011, 59 (03) : 632 - 633

← 1 2 3 4 5 →